SETTLEMENT AGREEMENT AND MUTUAL RELEASESettlement Agreement and Mutual Release • May 11th, 2009 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Settlement Agreement and Mutual Release (“Settlement Agreement”) is entered into by and between Ligand Pharmaceuticals Incorporated (“Ligand”) and The Rockefeller University (“Rockefeller”) (collectively, the “Parties”).
SEPARATION AGREEMENTSeparation Agreement • May 11th, 2009 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • California
This Separation Agreement (this “Agreement”) is entered into between Zofia E. Dziewanowska, M.D., Ph.D., an individual (“Executive”), and Ligand Pharmaceuticals Incorporated, (the “Company”), effective as of the Effective Date (as defined below).
RESEARCH AND LICENSE AGREEMENTResearch and License Agreement • May 11th, 2009 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New Jersey
THIS RESEARCH AND LICENSE AGREEMENT (the “Agreement”) is made and entered into as of the 5th day of February, 2009 (the “Effective Date”) by and between Trevena, Inc., a Delaware corporation, having a principal address at 1018 West 8th Ave. Building 11, King of Prussia, Pennsylvania 19406 (“Company”), and Ligand Pharmaceuticals, Inc., a Delaware corporation, having its principal place of business at 10275 Science Center Drive, San Diego, California 92121 (“Ligand”). Each of Company on one hand and Ligand on the other hand, is referred to as a “Party” and collectively as the “Parties.”
